Videos

Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, discusses the challenges of using ruxolitinib (Jakafi) in patients with myeloproliferative neoplasms (MPNs).

Dr. Cortes on the Challenges of Using Ruxolitinib in MPNs

Articles

Jorge E. Cortes, MD, discusses managing treatment toxicities to optimize therapeutic outcomes in patients with CML and MPNs.

Managing Treatment Toxicity in CML and MPNs

Jorge E. Cortes, MD, discusses the evolution of multiple myeloma treatment, the role of BCMA-directed therapies, and remaining questions that need to be addressed in this space

Cortes Underscores Rationale for BCMA-Directed Therapy in Multiple Myeloma

Jorge E. Cortes, MD, director of the Georgia Cancer Center at Augusta University, discusses the advantage of BCMA-targeted therapy in multiple myeloma.

Dr. Cortes on the Advantage of BCMA-Targeted Therapy in Multiple Myeloma

Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the AIM2CERV trial for patients with cervical cancer.

Dr. Ghamande on the AIM2CERV Trial in Cervical Cancer

Sharad Ghamande, MD, associate professor, Georgia Cancer Center, Augusta University, discusses the GOG/NRG-0265 study in cervical cancer.
 

Georgia Cancer Center at Augusta University

Latest from Georgia Cancer Center at Augusta University

New content coming soon, please check back later.